NEW YORK, NY / ACCESSWIRE / December 13, 2017 / The Dow and the S&P 500 closed at new record highs on Tuesday as the Federal Reserve's two-day policy meeting kicked off. The Dow Jones Industrial Average gained 0.49 percent to close at 24,504.80, while the S&P 500 Index rose 0.15 percent to close at 2,664.11. The Nasdaq Composite Index declined 0.19 percent to close at 6,862.32. The Fed is scheduled to announce their decision on an interest rate hike at 2 p.m. ET on Wednesday.

"As the rate hike tomorrow is highly priced in, it's not the decision itself that will be important, but how the Fed's views the economy. At the moment, markets are less optimistic about growth and inflation than the Fed," said Kjersti Haugland, chief economist at DNB, according to MarketWatch.

RDI Initiates Coverage on:

Inovio Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=INO

Sangamo Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=SGMO

Inovio Pharmaceuticals stock moved 5.56% lower Tuesday, to close the day at $4.25. The stock recorded a trading volume of 2,036,886 shares, which was above its three months average volume of 1,194,850 shares. In the last year, Inovio Pharmaceuticals shares have traded in a range of 4.20 - 9.86. The stock is currently trading 56.90% below its 52-week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.96 is below its 200-day moving average of $6.22. Shares of Inovio Pharmaceuticals have fallen roughly 10.34 percent in the past month and are down 38.76 percent year-to-date.

Access RDI's Inovio Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=INO

On Tuesday, shares in Sangamo Therapeutics, Inc. recorded a trading volume of 1,632,470 shares, which was above the three months average volume of 1,600,096 shares. The stock ended the day 1.58% higher at 16.10. The share price has gained 464.91% from its 52-week low with a 52-week trading range of 2.85 - 18.40.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $14.03 is greater than its 200-day moving average of $11.71. Shares of Sangamo Therapeutics have gained roughly 19.7 percent in the past month and are up 427.87 percent year-to-date.

Access RDI's Sangamo Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SGMO

Our Actionable Research on Inovio Pharmaceuticals, Inc. (NASDAQ :INO) and Sangamo Therapeutics, Inc. (NASDAQ :SGMO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com